Sylke Hassel

PharmaZell GmbH engages in the development and provision of pharmaceutical active ingredients. It also offers services for formulation development and compiles required regulatory documents for both the originator and generic pharmaceutical industry. Its products include manufactured amino acids and controlled substances. The company was founded in 1946 and is headquartered in Raubling, Germany.

PharmaZell GmbH engages in the development and provision of pharmaceutical active ingredients. It also offers services for formulation development and compiles required regulatory documents for both the originator and generic pharmaceutical industry. Its products include manufactured amino acids and controlled substances. The company was founded in 1946 and is headquartered in Raubling, Germany.

PharmaZell GmbH engages in the development and provision of pharmaceutical active ingredients. It also offers services for formulation development and compiles required regulatory documents for both the originator and generic pharmaceutical industry. Its products include manufactured amino acids and controlled substances. The company was founded in 1946 and is headquartered in Raubling, Germany.

Part of PharmaZell GmbH, Zellbios GmbH is a German company that specializes in manufacturing cdmo solutions, supplying specialty api products, and producing anticancer drugs. Zellbios is based in Raubling, DE, and Sylke Hassel has been the CEO of the company since 2022. The company offers a wide range of reliable services for small molecule apis and biopharmaceuticals to innovators. Zellbios also supports innovative agrochemical companies with their apis for fungicides, insecticides, and herbicides in a safe and sustainable way. The company provides cdmo services for highly potent apis and cytotoxics and is an expert in pre-formulated nitroglycerin production.